-
1
-
-
22944470530
-
Low-Dose Methotrexate: a mainstay in the treatment of rheumatoid arthritis
-
Cronstein B.N. Low-Dose Methotrexate: a mainstay in the treatment of rheumatoid arthritis. Pharmacol. Rev. 57 (2005) 163-172
-
(2005)
Pharmacol. Rev.
, vol.57
, pp. 163-172
-
-
Cronstein, B.N.1
-
3
-
-
14244269340
-
Psoriatic arthritis therapy: NSAIDs and traditional DMARDs
-
Nash P., and Clegg D.O. Psoriatic arthritis therapy: NSAIDs and traditional DMARDs. Ann. Rheum. Dis. 64 (2005) 74-77
-
(2005)
Ann. Rheum. Dis.
, vol.64
, pp. 74-77
-
-
Nash, P.1
Clegg, D.O.2
-
4
-
-
0029146767
-
Pancytopenia and severe cytopenia induced by low-dose methotrexate. Eight case-reports and a review of one hundred cases from the literature (with twenty-four deaths)
-
(Engl Ed)
-
Berthelot J.M., Maugars Y., Hamidou M., Chiffoleau A., Barrier J., Grolleau J.Y., et al. Pancytopenia and severe cytopenia induced by low-dose methotrexate. Eight case-reports and a review of one hundred cases from the literature (with twenty-four deaths). Rev. Rhum. 62 (1995) 477-486 (Engl Ed)
-
(1995)
Rev. Rhum.
, vol.62
, pp. 477-486
-
-
Berthelot, J.M.1
Maugars, Y.2
Hamidou, M.3
Chiffoleau, A.4
Barrier, J.5
Grolleau, J.Y.6
-
5
-
-
33747775544
-
Methotrexate pharmacogenomics
-
Kremer J.M. Methotrexate pharmacogenomics. Ann. Rheum. Dis. 65 (2006) 1121-1123
-
(2006)
Ann. Rheum. Dis.
, vol.65
, pp. 1121-1123
-
-
Kremer, J.M.1
-
6
-
-
1542359519
-
Folate supplementation and methotrexate treatment in rheumatid arthritis: a review
-
Wittle S.L., and Hughes R.A. Folate supplementation and methotrexate treatment in rheumatid arthritis: a review. Rheumatol. 43 (2004) 267-271
-
(2004)
Rheumatol.
, vol.43
, pp. 267-271
-
-
Wittle, S.L.1
Hughes, R.A.2
-
7
-
-
0030023020
-
Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis
-
Guttierez-Urena S., Molina J.F., Garcia C.O., Cuellar M.L., and Espinosa L.R. Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis. Arthritis Rheum. 39 (1996) 272-276
-
(1996)
Arthritis Rheum.
, vol.39
, pp. 272-276
-
-
Guttierez-Urena, S.1
Molina, J.F.2
Garcia, C.O.3
Cuellar, M.L.4
Espinosa, L.R.5
-
8
-
-
24944511275
-
Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in five years
-
Lim A.Y., Gaffney K., and Scott D.G. Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in five years. Rheumatol. 44 (2005) 1051-1055
-
(2005)
Rheumatol.
, vol.44
, pp. 1051-1055
-
-
Lim, A.Y.1
Gaffney, K.2
Scott, D.G.3
-
9
-
-
0030956063
-
Prospectively measured red cell folate levels in methotrexate treated patients with rheumatoid arthritis: relation to withdrawal and side effects
-
Andersen L.S., Hansen E.L., Knudsen J.B., Wester J.U., Hansen G.V., and Hansen T.M. Prospectively measured red cell folate levels in methotrexate treated patients with rheumatoid arthritis: relation to withdrawal and side effects. J. Rheumatol. 24 (1997) 830-837
-
(1997)
J. Rheumatol.
, vol.24
, pp. 830-837
-
-
Andersen, L.S.1
Hansen, E.L.2
Knudsen, J.B.3
Wester, J.U.4
Hansen, G.V.5
Hansen, T.M.6
-
10
-
-
0025037994
-
The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis
-
Morgan S.L., Baggott J.E., Vaughn W.H., Young P.K., Austin J.V., Krumdieck C.L., et al. The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum. 33 (1990) 9-18
-
(1990)
Arthritis Rheum.
, vol.33
, pp. 9-18
-
-
Morgan, S.L.1
Baggott, J.E.2
Vaughn, W.H.3
Young, P.K.4
Austin, J.V.5
Krumdieck, C.L.6
-
11
-
-
0028593942
-
Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis: a double-blind, placebo-controlled trial
-
Morgan S.L., Baggott J.E., Vaughn W.H., Young P.K., Austin J.S., Krumdieck C.L., et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis: a double-blind, placebo-controlled trial. Ann. Intern. Med. 121 (1994) 833-841
-
(1994)
Ann. Intern. Med.
, vol.121
, pp. 833-841
-
-
Morgan, S.L.1
Baggott, J.E.2
Vaughn, W.H.3
Young, P.K.4
Austin, J.S.5
Krumdieck, C.L.6
-
12
-
-
0024845269
-
Elevated mean corpuscular volume as a predictor of hematologic toxicity due to methotrexate therapy
-
Weinblatt M.E., and Fraser P. Elevated mean corpuscular volume as a predictor of hematologic toxicity due to methotrexate therapy. Arthritis Rheum. 32 (1989) 1592-1596
-
(1989)
Arthritis Rheum.
, vol.32
, pp. 1592-1596
-
-
Weinblatt, M.E.1
Fraser, P.2
-
13
-
-
27144498964
-
Pancytopenia after a single intradermal infiltration of methotrexate
-
Cohen P.R., Schulze K.E., and Nelson B.R. Pancytopenia after a single intradermal infiltration of methotrexate. J. Drugs Dermatol. 4 (2005) 648-651
-
(2005)
J. Drugs Dermatol.
, vol.4
, pp. 648-651
-
-
Cohen, P.R.1
Schulze, K.E.2
Nelson, B.R.3
-
14
-
-
22144458739
-
Pancytopenia induced by low-dose methotrexate. A study of cses reported to the finnish adverse drug reaction register from 1991 to 1999
-
Kuitunen T., Malmström J., Palva E., and Pettersson T. Pancytopenia induced by low-dose methotrexate. A study of cses reported to the finnish adverse drug reaction register from 1991 to 1999. Scand. J. Rheumatol. 34 (2005) 238-241
-
(2005)
Scand. J. Rheumatol.
, vol.34
, pp. 238-241
-
-
Kuitunen, T.1
Malmström, J.2
Palva, E.3
Pettersson, T.4
|